Christopher Korch
Concepts (317)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microsatellite Repeats | 1 | 2026 | 157 | 0.910 |
Why?
| | Cell Line, Tumor | 21 | 2021 | 3540 | 0.790 |
Why?
| | HeLa Cells | 3 | 2021 | 650 | 0.650 |
Why?
| | Intestines | 1 | 2021 | 358 | 0.560 |
Why?
| | Algorithms | 1 | 2026 | 1837 | 0.550 |
Why?
| | Thyroid Neoplasms | 7 | 2019 | 345 | 0.480 |
Why?
| | Saccharomyces cerevisiae | 9 | 1999 | 579 | 0.400 |
Why?
| | Fungal Proteins | 4 | 2021 | 145 | 0.390 |
Why?
| | Biomedical Research | 3 | 2026 | 710 | 0.340 |
Why?
| | Melanoma | 2 | 2017 | 761 | 0.340 |
Why?
| | Endometrial Neoplasms | 1 | 2012 | 208 | 0.310 |
Why?
| | Breast Neoplasms | 3 | 2017 | 2452 | 0.290 |
Why?
| | Genes, Fungal | 5 | 1999 | 55 | 0.270 |
Why?
| | Cell Line | 3 | 2026 | 2882 | 0.270 |
Why?
| | Proto-Oncogene Proteins B-raf | 3 | 2019 | 225 | 0.270 |
Why?
| | Gene Expression Regulation, Fungal | 4 | 1998 | 78 | 0.270 |
Why?
| | Tumor Suppressor Protein p53 | 5 | 2019 | 529 | 0.260 |
Why?
| | Fluorescent Dyes | 2 | 1999 | 329 | 0.260 |
Why?
| | GTPase-Activating Proteins | 3 | 2012 | 82 | 0.250 |
Why?
| | Ovarian Neoplasms | 2 | 2012 | 586 | 0.250 |
Why?
| | Sequence Analysis, DNA | 2 | 1999 | 824 | 0.230 |
Why?
| | Base Sequence | 13 | 1999 | 2190 | 0.230 |
Why?
| | DNA, Neoplasm | 4 | 2017 | 163 | 0.220 |
Why?
| | Methionine | 4 | 1993 | 162 | 0.210 |
Why?
| | Mutation | 14 | 2019 | 4089 | 0.200 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2019 | 433 | 0.190 |
Why?
| | Neisseria gonorrhoeae | 5 | 1986 | 29 | 0.190 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2013 | 1455 | 0.190 |
Why?
| | Thyroid Carcinoma, Anaplastic | 3 | 2019 | 36 | 0.190 |
Why?
| | Adenocarcinoma, Follicular | 3 | 2019 | 41 | 0.180 |
Why?
| | Plasmids | 6 | 1999 | 379 | 0.180 |
Why?
| | Cell Culture Techniques | 2 | 2019 | 375 | 0.180 |
Why?
| | Saccharomyces cerevisiae Proteins | 3 | 1999 | 419 | 0.170 |
Why?
| | Cloning, Molecular | 7 | 1999 | 540 | 0.170 |
Why?
| | Genotype | 1 | 2026 | 1833 | 0.170 |
Why?
| | Drug Discovery | 1 | 2021 | 155 | 0.160 |
Why?
| | Trans-Activators | 2 | 1993 | 405 | 0.160 |
Why?
| | Manganese Compounds | 1 | 1999 | 4 | 0.150 |
Why?
| | Genetic Carrier Screening | 1 | 1999 | 32 | 0.150 |
Why?
| | Rhodamines | 1 | 1999 | 21 | 0.150 |
Why?
| | Citric Acid | 1 | 1999 | 34 | 0.140 |
Why?
| | DNA, Bacterial | 5 | 1986 | 342 | 0.140 |
Why?
| | Histone Deacetylase Inhibitors | 2 | 2011 | 220 | 0.140 |
Why?
| | DNA Restriction Enzymes | 3 | 1987 | 53 | 0.140 |
Why?
| | Alleles | 3 | 2007 | 879 | 0.140 |
Why?
| | Neoplasm Proteins | 3 | 2011 | 442 | 0.140 |
Why?
| | Organometallic Compounds | 1 | 1999 | 112 | 0.130 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 253 | 0.130 |
Why?
| | Molecular Sequence Data | 8 | 1999 | 2930 | 0.130 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2017 | 322 | 0.130 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 210 | 0.130 |
Why?
| | Telomerase | 1 | 2019 | 248 | 0.120 |
Why?
| | DNA Polymerase I | 2 | 1993 | 31 | 0.120 |
Why?
| | Carcinoma | 2 | 2011 | 228 | 0.120 |
Why?
| | Humans | 28 | 2026 | 144759 | 0.120 |
Why?
| | DNA, Fungal | 3 | 1999 | 83 | 0.120 |
Why?
| | DNA-Binding Proteins | 2 | 1993 | 1499 | 0.110 |
Why?
| | Chromosomes, Fungal | 2 | 1993 | 40 | 0.110 |
Why?
| | rap1 GTP-Binding Proteins | 2 | 2012 | 6 | 0.110 |
Why?
| | rap GTP-Binding Proteins | 2 | 2012 | 9 | 0.110 |
Why?
| | Carcinoma, Papillary | 2 | 2012 | 79 | 0.110 |
Why?
| | DNA Fingerprinting | 2 | 2012 | 32 | 0.110 |
Why?
| | Gene Expression Profiling | 3 | 2010 | 1782 | 0.100 |
Why?
| | Hydroxamic Acids | 2 | 2011 | 94 | 0.100 |
Why?
| | Neuropilin-2 | 1 | 2013 | 4 | 0.100 |
Why?
| | Carcinoma, Renal Cell | 2 | 2007 | 234 | 0.100 |
Why?
| | Cell Movement | 3 | 2013 | 965 | 0.100 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2013 | 339 | 0.100 |
Why?
| | Lymphoma, B-Cell, Marginal Zone | 1 | 2013 | 19 | 0.100 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2013 | 26 | 0.100 |
Why?
| | Leucine Zippers | 1 | 1993 | 17 | 0.100 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2013 | 105 | 0.100 |
Why?
| | Pyrimidines | 2 | 2013 | 532 | 0.100 |
Why?
| | Nuclear Proteins | 2 | 2013 | 748 | 0.100 |
Why?
| | Mucin-1 | 1 | 2012 | 22 | 0.090 |
Why?
| | Hepatocyte Growth Factor | 1 | 2012 | 33 | 0.090 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 178 | 0.090 |
Why?
| | Transcription, Genetic | 4 | 1993 | 1496 | 0.090 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2013 | 124 | 0.090 |
Why?
| | DNA | 1 | 1999 | 1463 | 0.090 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1991 | 11 | 0.090 |
Why?
| | Amino Acid Sequence | 7 | 1998 | 2155 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2012 | 75 | 0.090 |
Why?
| | Kidney Neoplasms | 2 | 2007 | 412 | 0.090 |
Why?
| | Threonine | 1 | 1991 | 46 | 0.090 |
Why?
| | Stomach Neoplasms | 1 | 2013 | 126 | 0.090 |
Why?
| | Estrogen Receptor alpha | 1 | 2013 | 161 | 0.090 |
Why?
| | Phosphotransferases | 1 | 1991 | 27 | 0.090 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2013 | 219 | 0.090 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2012 | 162 | 0.090 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 1991 | 48 | 0.090 |
Why?
| | Cell Proliferation | 6 | 2019 | 2496 | 0.090 |
Why?
| | Models, Biological | 1 | 2019 | 1821 | 0.090 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2013 | 881 | 0.090 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1991 | 96 | 0.080 |
Why?
| | Cytoskeleton | 1 | 2012 | 195 | 0.080 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 31 | 0.080 |
Why?
| | Prostatic Neoplasms | 3 | 2003 | 974 | 0.080 |
Why?
| | Butyrates | 1 | 2011 | 67 | 0.080 |
Why?
| | Receptor, IGF Type 1 | 1 | 2010 | 64 | 0.080 |
Why?
| | Valproic Acid | 1 | 2010 | 47 | 0.080 |
Why?
| | Cytosine | 3 | 1986 | 51 | 0.080 |
Why?
| | Amino Acids | 2 | 1993 | 521 | 0.080 |
Why?
| | Estradiol | 1 | 2013 | 533 | 0.080 |
Why?
| | Pyrazoles | 1 | 2013 | 509 | 0.080 |
Why?
| | Cell Cycle Proteins | 1 | 2013 | 628 | 0.070 |
Why?
| | Pyrazines | 1 | 2010 | 92 | 0.070 |
Why?
| | Osteosarcoma | 1 | 2010 | 76 | 0.070 |
Why?
| | Germ-Line Mutation | 1 | 2010 | 172 | 0.070 |
Why?
| | Lymphoma | 1 | 2011 | 232 | 0.070 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2010 | 139 | 0.070 |
Why?
| | Prospective Studies | 1 | 2021 | 7990 | 0.070 |
Why?
| | Vitamin D | 1 | 2012 | 400 | 0.070 |
Why?
| | Imidazoles | 1 | 2010 | 254 | 0.070 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2012 | 370 | 0.070 |
Why?
| | Cell Adhesion | 1 | 2010 | 455 | 0.070 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1313 | 0.070 |
Why?
| | Tumor Cells, Cultured | 3 | 2013 | 919 | 0.070 |
Why?
| | Signal Transduction | 2 | 2012 | 5226 | 0.070 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2007 | 43 | 0.070 |
Why?
| | Peptide Fragments | 1 | 1991 | 699 | 0.070 |
Why?
| | Doxorubicin | 1 | 2010 | 397 | 0.070 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2007 | 38 | 0.070 |
Why?
| | Translocation, Genetic | 1 | 2007 | 115 | 0.060 |
Why?
| | Reproducibility of Results | 4 | 2019 | 3409 | 0.060 |
Why?
| | Antineoplastic Agents | 2 | 2011 | 2194 | 0.060 |
Why?
| | Drug Delivery Systems | 1 | 2010 | 380 | 0.060 |
Why?
| | Female | 11 | 2019 | 78271 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2012 | 780 | 0.060 |
Why?
| | Extracellular Matrix | 1 | 2010 | 553 | 0.060 |
Why?
| | Disease Susceptibility | 1 | 2007 | 348 | 0.060 |
Why?
| | Mice, Nude | 3 | 2013 | 682 | 0.060 |
Why?
| | Drug Synergism | 3 | 2013 | 357 | 0.060 |
Why?
| | Receptors, Cell Surface | 1 | 2007 | 377 | 0.060 |
Why?
| | Genes, Bacterial | 1 | 1985 | 166 | 0.060 |
Why?
| | Neoplasm Transplantation | 2 | 2019 | 251 | 0.060 |
Why?
| | Animals | 10 | 2019 | 38058 | 0.050 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 1180 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2013 | 928 | 0.050 |
Why?
| | Chromosomes, Bacterial | 3 | 1986 | 13 | 0.050 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 969 | 0.050 |
Why?
| | Quinazolines | 1 | 2005 | 266 | 0.050 |
Why?
| | Mice | 7 | 2019 | 18339 | 0.050 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2005 | 192 | 0.050 |
Why?
| | Sirolimus | 1 | 2005 | 281 | 0.050 |
Why?
| | 2-Isopropylmalate Synthase | 2 | 1993 | 2 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2021 | 17066 | 0.050 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 1993 | 42 | 0.050 |
Why?
| | Methyltransferases | 1 | 1983 | 74 | 0.050 |
Why?
| | Tumor Suppressor Proteins | 1 | 2005 | 321 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2010 | 845 | 0.040 |
Why?
| | Restriction Mapping | 2 | 1991 | 80 | 0.040 |
Why?
| | Blotting, Northern | 2 | 1991 | 204 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 2363 | 0.040 |
Why?
| | Calcitriol | 2 | 2012 | 58 | 0.040 |
Why?
| | Protein Kinases | 2 | 2005 | 315 | 0.040 |
Why?
| | Chromosome Mapping | 2 | 1993 | 510 | 0.040 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1953 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 2145 | 0.040 |
Why?
| | Drug Resistance, Microbial | 3 | 1999 | 69 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2011 | 191 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 2013 | 2637 | 0.040 |
Why?
| | Dideoxynucleosides | 1 | 1999 | 22 | 0.040 |
Why?
| | Up-Regulation | 2 | 2013 | 851 | 0.040 |
Why?
| | Validation Studies as Topic | 1 | 2019 | 23 | 0.040 |
Why?
| | beta Catenin | 2 | 2012 | 252 | 0.040 |
Why?
| | Cell Lineage | 1 | 2001 | 376 | 0.040 |
Why?
| | Leucine | 1 | 1999 | 116 | 0.040 |
Why?
| | Quality Control | 1 | 2019 | 163 | 0.040 |
Why?
| | Toxicology | 1 | 2019 | 49 | 0.040 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2001 | 255 | 0.030 |
Why?
| | RNA, Small Interfering | 2 | 2011 | 635 | 0.030 |
Why?
| | Candida albicans | 1 | 1998 | 61 | 0.030 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2007 | 16 | 0.030 |
Why?
| | Protein Binding | 2 | 2013 | 2273 | 0.030 |
Why?
| | Genes, ras | 2 | 2010 | 96 | 0.030 |
Why?
| | DNA Mutational Analysis | 2 | 2001 | 406 | 0.030 |
Why?
| | 5-Methylcytosine | 2 | 1986 | 25 | 0.030 |
Why?
| | Fungi | 1 | 1997 | 161 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 983 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 549 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2019 | 4557 | 0.030 |
Why?
| | Aspartic Acid | 1 | 1974 | 88 | 0.030 |
Why?
| | Tumor Stem Cell Assay | 1 | 2013 | 34 | 0.030 |
Why?
| | Substrate Specificity | 2 | 1985 | 388 | 0.020 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2013 | 49 | 0.020 |
Why?
| | Apoptosis | 2 | 2013 | 2430 | 0.020 |
Why?
| | Cell Cycle Checkpoints | 1 | 2013 | 99 | 0.020 |
Why?
| | MCF-7 Cells | 1 | 2013 | 135 | 0.020 |
Why?
| | Response Elements | 1 | 2013 | 89 | 0.020 |
Why?
| | Ki-67 Antigen | 1 | 2013 | 117 | 0.020 |
Why?
| | Cholestanetriol 26-Monooxygenase | 1 | 2012 | 7 | 0.020 |
Why?
| | Steroid Hydroxylases | 1 | 2012 | 20 | 0.020 |
Why?
| | Pyrimidinones | 1 | 2013 | 126 | 0.020 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 2012 | 16 | 0.020 |
Why?
| | Cytochrome P450 Family 2 | 1 | 2012 | 12 | 0.020 |
Why?
| | Karyotyping | 2 | 2003 | 106 | 0.020 |
Why?
| | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2012 | 18 | 0.020 |
Why?
| | TATA-Box Binding Protein | 1 | 2012 | 21 | 0.020 |
Why?
| | Purines | 1 | 1974 | 187 | 0.020 |
Why?
| | HT29 Cells | 1 | 2012 | 37 | 0.020 |
Why?
| | Proto-Oncogene Proteins pp60(c-src) | 1 | 2012 | 14 | 0.020 |
Why?
| | Gene Expression | 2 | 2013 | 1490 | 0.020 |
Why?
| | Cholecalciferol | 1 | 2012 | 60 | 0.020 |
Why?
| | Tumor Burden | 1 | 2013 | 319 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2013 | 172 | 0.020 |
Why?
| | Blotting, Southern | 1 | 1991 | 85 | 0.020 |
Why?
| | Densitometry | 1 | 1991 | 37 | 0.020 |
Why?
| | Escherichia coli | 1 | 1976 | 854 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 1991 | 77 | 0.020 |
Why?
| | S-Adenosylmethionine | 1 | 1991 | 59 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 269 | 0.020 |
Why?
| | Spores | 1 | 1971 | 3 | 0.020 |
Why?
| | RNA Nucleotidyltransferases | 1 | 1971 | 23 | 0.020 |
Why?
| | Codon | 1 | 1991 | 94 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2012 | 167 | 0.020 |
Why?
| | Sulfur | 1 | 1991 | 64 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 60 | 0.020 |
Why?
| | RNA, Neoplasm | 1 | 2010 | 86 | 0.020 |
Why?
| | RNA Interference | 1 | 2012 | 476 | 0.020 |
Why?
| | Bacillus subtilis | 1 | 1971 | 69 | 0.020 |
Why?
| | Li-Fraumeni Syndrome | 1 | 2010 | 15 | 0.020 |
Why?
| | Adherens Junctions | 1 | 2010 | 24 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2012 | 288 | 0.020 |
Why?
| | Molecular Epidemiology | 1 | 2010 | 73 | 0.020 |
Why?
| | Population Groups | 1 | 2010 | 58 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 940 | 0.020 |
Why?
| | Mice, SCID | 1 | 2011 | 369 | 0.020 |
Why?
| | Down-Regulation | 1 | 2012 | 627 | 0.020 |
Why?
| | Azacitidine | 1 | 2011 | 156 | 0.020 |
Why?
| | Piperazines | 1 | 2012 | 381 | 0.020 |
Why?
| | Gene Dosage | 1 | 2010 | 148 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2010 | 93 | 0.020 |
Why?
| | Paclitaxel | 1 | 2010 | 255 | 0.020 |
Why?
| | Australia | 1 | 2010 | 286 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2010 | 336 | 0.020 |
Why?
| | Gene Silencing | 1 | 2010 | 205 | 0.020 |
Why?
| | Species Specificity | 1 | 2010 | 574 | 0.020 |
Why?
| | Dogs | 1 | 2010 | 437 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 1991 | 675 | 0.020 |
Why?
| | Cadherins | 1 | 2010 | 201 | 0.020 |
Why?
| | Indoles | 1 | 2012 | 501 | 0.020 |
Why?
| | Sulfonamides | 1 | 2012 | 580 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2182 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1732 | 0.020 |
Why?
| | Acid Anhydride Hydrolases | 1 | 2007 | 7 | 0.020 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2007 | 20 | 0.020 |
Why?
| | Phenotype | 2 | 1993 | 3162 | 0.020 |
Why?
| | Cell Cycle | 1 | 2010 | 596 | 0.020 |
Why?
| | Male | 7 | 2013 | 72315 | 0.020 |
Why?
| | Siblings | 1 | 2007 | 195 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2010 | 618 | 0.020 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2013 | 682 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 35875 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 2008 | 259 | 0.010 |
Why?
| | DNA Methylation | 1 | 2011 | 681 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2010 | 1095 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1987 | 337 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2027 | 0.010 |
Why?
| | Family | 1 | 2010 | 679 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1985 | 187 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 1986 | 205 | 0.010 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 1985 | 37 | 0.010 |
Why?
| | Liver | 1 | 2012 | 1887 | 0.010 |
Why?
| | Adenine | 2 | 1998 | 339 | 0.010 |
Why?
| | Binding Sites | 1 | 1986 | 1329 | 0.010 |
Why?
| | Keratins | 1 | 2003 | 172 | 0.010 |
Why?
| | Prostate-Specific Antigen | 1 | 2003 | 161 | 0.010 |
Why?
| | Methylation | 1 | 1983 | 242 | 0.010 |
Why?
| | Receptors, Androgen | 1 | 2003 | 153 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1985 | 458 | 0.010 |
Why?
| | Nucleic Acid Conformation | 1 | 1985 | 726 | 0.010 |
Why?
| | Bacterial Proteins | 2 | 1986 | 955 | 0.010 |
Why?
| | ErbB Receptors | 1 | 2005 | 627 | 0.010 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2005 | 449 | 0.010 |
Why?
| | Cytogenetics | 1 | 2001 | 11 | 0.010 |
Why?
| | Genes, Neoplasm | 1 | 2001 | 25 | 0.010 |
Why?
| | Blotting, Western | 1 | 2003 | 1187 | 0.010 |
Why?
| | Chromosome Aberrations | 1 | 2001 | 162 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2008 | 2832 | 0.010 |
Why?
| | DNA Primers | 1 | 2001 | 512 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 1999 | 66 | 0.010 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 1999 | 9 | 0.010 |
Why?
| | Porins | 1 | 1999 | 18 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2003 | 1716 | 0.010 |
Why?
| | Amino Acid Transport Systems | 1 | 1999 | 43 | 0.010 |
Why?
| | Aged | 1 | 2019 | 25913 | 0.010 |
Why?
| | Histidine Kinase | 1 | 1998 | 34 | 0.010 |
Why?
| | Thymine | 1 | 1998 | 17 | 0.010 |
Why?
| | Membrane Transport Proteins | 1 | 1999 | 154 | 0.010 |
Why?
| | Biological Transport | 1 | 1999 | 417 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2001 | 612 | 0.010 |
Why?
| | Guanine | 1 | 1998 | 87 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1998 | 366 | 0.010 |
Why?
| | Aspergillus niger | 1 | 1997 | 10 | 0.010 |
Why?
| | Neurospora crassa | 1 | 1997 | 23 | 0.010 |
Why?
| | Genetic Techniques | 1 | 1997 | 67 | 0.010 |
Why?
| | Gene Library | 1 | 1997 | 126 | 0.010 |
Why?
| | Muramidase | 1 | 1976 | 67 | 0.010 |
Why?
| | Cell Wall | 1 | 1976 | 61 | 0.010 |
Why?
| | Surface-Active Agents | 1 | 1976 | 92 | 0.010 |
Why?
| | Adult | 2 | 2010 | 40449 | 0.010 |
Why?
| | DNA Replication | 1 | 1976 | 251 | 0.010 |
Why?
| | Orotic Acid | 1 | 1974 | 3 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1997 | 1054 | 0.010 |
Why?
| | Uracil | 1 | 1974 | 36 | 0.010 |
Why?
| | Carbamates | 1 | 1974 | 52 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 1998 | 905 | 0.010 |
Why?
| | Microscopy, Phase-Contrast | 1 | 1971 | 18 | 0.010 |
Why?
| | Genetics, Microbial | 1 | 1971 | 11 | 0.010 |
Why?
| | Bacteriological Techniques | 1 | 1971 | 68 | 0.010 |
Why?
| | Culture Media | 1 | 1971 | 161 | 0.010 |
Why?
| | Rifampin | 1 | 1971 | 82 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1971 | 415 | 0.010 |
Why?
| | Genes | 1 | 1986 | 226 | 0.000 |
Why?
| | Chromosome Deletion | 1 | 1986 | 124 | 0.000 |
Why?
| | Models, Genetic | 1 | 1986 | 536 | 0.000 |
Why?
|
|
Korch's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|